STgen Bio (formerly DM Bio) is a CMO specializing in the development and manufacturing of mammalian cell culture based therapeutic proteins and monoclonal antibodies. STgen Bio started as a joint venture between Dong-A Socio Holdings and Meiji Seika Pharma, which both have long histories in the pharmaceutical industry of Korea and Japan, respectively. Since its first manufacture in 2015, STgen Bio dedicates itself to matching specific demands of global biotechnology companies with highly qualified experts and state-of-the-art manufacturing facilities.
Company Details
- Employees
- 72
- Founded
- -
- Address
- 45, Jisikgiban-Ro, Yeonsu-Gu,incheon 21990,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- dmbio.com
- Keywords
- Best Biologics CDMO: Quality.
- HQ
- Yeonsu-gu, Incheon
Stgen Bio Questions
Stgen Bio's website is dmbio.com
Stgen Bio's LinkedIn profile is https://kr.linkedin.com/company/stgenbio
Stgen Bio has
72 employees.
View email and phone details for 72
employees at Stgen Bio.
Stgen Bio's industry is
Biotechnology Research
Stgen Bio's top competitors are
Protium Science - Cdmo,
Celltrion Inc,
Sk Bioscience,
Daewoong Pharmaceutical,
Tiumbio,
St Pharm,
Sk Pharmteco,
Imprimedkorea,
Samsung Biologics,
Lotte Biologics.
Stgen Bio's categories are Biotechnology Research
Stgen Bio's founding year is 2015
